Blood cancer, which originates from irregular blood cell generation within the bone marrow, represents a serious health ...

With a new leadership team and fast-track designation from the US Food and Drug Administration (FDA), clinical-stage oncology ...

Staying on top of your health involves more than just feeling good – it's about knowing what's happening beneath the surface.

A common hay fever trigger could be treated by placing a "molecular shield" in the nose within five years. Scientists have ...

Patients who receive avacopan for antineutrophil cytoplasmic antibody-associated vasculitis demonstrate fewer infections and ...

Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...

The Medipost CEO discusses developing treatments for knee osteoarthritis and other conditions.

Every three minutes, about one person is diagnosed with a form of blood cancer for which the treatment could require a bone ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

A “MOLECULAR shield” placed in the nose could prevent hay fever symptoms, a study suggests. Scientists have engineered an ...

Despite more complex reproductive organs and fewer resources, female bodies are built to get through hardship and disease, ...

Acute Myeloid Leukemia (AML), an aggressive form of blood cancer, has long been a significant challenge for patients and doctors in India. But recent medical breakthroughs—including the recent approva ...